| Nearly 1 million people in the U.S. live with CHD
Atrial and ventricular arrhythmias are a major cause of late morbidity and mortality in patients with congenital heart disease, whose care typically requires multimodality strategies involving anti-arrhythmic drugs, detailed electrophysiological studies, radiofrequency catheter ablation and device therapy.
Mayo specialists improve the odds of successful outcomes for pregnant patients with congenital defects
Declining cases of rheumatic heart disease and improved survival of patients with congenital heart disease have resulted in congenital defects being the most common cause of maternal heart disease affecting pregnancy in the U.S.
|
|
19th Annual Mayo Cardiovascular Review Course for Cardiology Boards and Recertification With Echo Focus Session (Aug. 15)
Aug. 15-20, 2014, in Rochester, Minn.
This comprehensive, immersive review includes the topics board-certified cardiologists require to manage, including interpretation of ECG and EP tracings, management of patients with valvular heart disease, and analysis of hemodynamic catheterization traces.
Advances in Pathophysiology and Emerging Novel Therapeutic Strategies
Oct. 10-11, 2014, in Boston
Program topic highlights include emerging novel therapeutics to reduce the gap in care for patients with valve disease, hypertrophic cardiomyopathy, atrial fibrillations and heart failure. Presentations and discussions emphasize changing concepts of disease pathophysiology and treatment.
30th Annual Echocardiography in Pediatric and Adult Congenital Heart Disease
Oct. 15-19, 2014, in Phoenix
The symposium offers a clinical-case-based format that explores the use of echocardiography and other cardiac imaging techniques to help cardiologists recognize, understand and manage patients with congenital heart disease. Presentations also address anatomy and clinical aspects.
See all Cardiovascular Diseases Continuous Professional Development courses |
